E-LIB Suche - Ergebnisse für: Halamoda-Kenzaoui, Blanka

1

Future perspectives for advancing regulatory science of nan..:

Halamoda-Kenzaoui, Blanka ; Geertsma, Robert ; Pouw, Joost...
Drug Delivery and Translational Research. 12 (2022) 9 - p. 2145-2156 , 2022

Link: https://doi.org/10.1007/..

2

Tiered testing of micro- and nanoplastics using intestinal ..:

Bredeck, Gerrit ; Halamoda-Kenzaoui, Blanka ; Bogni, Alessia..
Environment International. 158 (2022) - p. 106921 , 2022

Link: https://doi.org/10.1016/..

3

Launching stakeholder discussions on identified regulatory ..:

Halamoda-Kenzaoui, Blanka ; Box, Helen ; van Elk, Merel...
Precision Nanomedicine. 3 (2020) 2 - p. , 2020

Link: https://doi.org/10.33218..

4

Bridging communities in the field of nanomedicine:

Halamoda-Kenzaoui, Blanka ; Baconnier, Simon ; Bastogne, Thierry...
Regulatory Toxicology and Pharmacology. 106 (2019) - p. 187-196 , 2019

Link: https://doi.org/10.1016/..

5

Main trends of immune effects triggered by nanomedicines in..:

Halamoda-Kenzaoui, Blanka ; Bremer-Hoffmann, Susanne
International Journal of Nanomedicine. 13 (2018) - p. 5419-5431 , 2018

Link: https://doi.org/10.2147/..

6

The agglomeration state of nanoparticles can influence the ..:

Halamoda-Kenzaoui, Blanka ; Ceridono, Mara ; Urbán, Patricia...
Journal of Nanobiotechnology. 15 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

7

Identification of regulatory needs for nanomedicines: 1st E..

EUR, Scientific and technical research series, 28224

Bremer, Susanne ; Halamoda-Kenzaoui, Blanka ; Borgos, Sven Even , 2016

Link: http://dx.publications.e..

8

Identification of regulatory needs for nanomedicines: 1st E..

EUR, Scientific and technical research series, 28224

Bremer, Susanne ; Halamoda-Kenzaoui, Blanka ; Borgos, Sven Even , 2016

Link: http://dx.publications.e..

9

Modulation of surface bio-functionality by using gold nanos..:

Muldur, Sinan K. ; Desmet, Cloe ; La Spina, Rita...
RSC Advances. 5 (2015) 101 - p. 83187-83196 , 2015

Link: https://doi.org/10.1039/..

10

Dispersion Behaviour of Silica Nanoparticles in Biological ..:

Halamoda-Kenzaoui, Blanka ; Ceridono, Mara ; Colpo, Pascal...
PLOS ONE. 10 (2015) 10 - p. e0141593 , 2015

Link: https://doi.org/10.1371/..

11

Future perspectives for advancing regulatory science of nan..:

Halamoda-Kenzaoui, Blanka ; Geertsma, Robert ; Pouw, Joost...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360093/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Methodological needs in the quality and safety characterisa..:

Halamoda-Kenzaoui, Blanka ; Vandebriel, Rob ; Howarth, A...
Halamoda-Kenzaoui , B , Vandebriel , R , Howarth , A , Siccardi , M , David , C A W , Liptrott , J , Santin , M , Borgos , S , Bremer-Hoffmann , S & Caputo , F 2021 , ' Methodological needs in the quality and safety characterisation of nanotechnology-based health products : Priorities for method development and standardisation ' , Journal of Controlled Release , vol. 336 , pp. 192-206 . https://doi.org/10.1016/j.jconrel.2021.06.016. , 2021

Link: https://research.brighto..

13

Methodological needs in the quality and safety characterisa..:

Halamoda-Kenzaoui, Blanka ; Vandebriel, Rob ; Howarth, Alice...
Journal of Controlled Release, 2021, 336, 192-206.. , 2021

Link: https://hdl.handle.net/1..

14

Methodological needs in the quality and safety characterisa..:

Halamoda-Kenzaoui, Blanka ; Vandebriel, Rob ; Howarth, Alice...
Journal of Controlled Release. 2021, 336 192-206.. , 2021

Link: https://hdl.handle.net/1..

15

Emerging technologies and their impact on regulatory scienc:

Anklam, Elke ; Bahl, Martin Iain ; Ball, Robert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749227/. , 2021

Link: http://www.ncbi.nlm.nih...